Find & Match With Recruiters
Get unlimited access to premium research & analysis
PE deal volume and value rose slightly in Q3; Archimed buys Ark Diagnostics in $428m carveout
1 min read

PE deal volume and value rose slightly in Q3; Archimed buys Ark Diagnostics in $428m carveout

PE deal volume and value rose slightly in Q3; Archimed buys Ark Diagnostics in $428m carveout

Executive Summary

Deal Analysis & Market Intelligence

PE deal volume and value rose slightly in Q3; Archimed buys Ark Diagnostics in $428m carveout

PE deal volume and value rose slightly in Q3; Archimed buys Ark Diagnostics in $428m carveout

PE deal volume and value rose slightly in Q3; A...

This $428m transaction represents significant deal activity. This deal activity signals continued strategic positioning in the sector.

Updated Oct 28, 2025

Deal Value Comparison

Chart Analysis
  • YTD High leads with 599 m, the highest value across all 4 categories analyzed.
  • YTD Low trails at the lowest position with 150 m, a 75% gap from the leader.
  • The average across all categories is 375 m.
  • 2 out of 4 categories perform above average.

Strategic Drivers

Chart Analysis
  • Market Position dominates with 35.0% market share, representing the largest segment in this distribution.
  • The second largest segment is Growth Potential at 28.0%, trailing by 7.0 percentage points.
  • The remaining 2 segments collectively represent 37.0% of the total.

Premium Analysis

Subscribe to unlock full market intelligence

Ask Senna Ask about this article... AI